DAM
OACCW

DLD Asset Management’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

DLD Asset Management’s Portfolio OACCW Stock Details OACCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-40,273
Closed -$30.2K – 301
2025
Q1 		$30.2K Buy
+40,273
New +$30.6K ﹤0.01% 130

Other funds holding OACCW

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BGGS
Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

DLD Asset Management's OACCW Position: Q2 2026 in Review

DLD Asset Management opened a new position in Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) in Q2 2026: 44,519 shares worth $41.9K. The stake represents ﹤0.01% of the portfolio and ranks #336 among its holdings. This is a return to the name: DLD Asset Management previously reported a position in OACCW as recently as Q4 2025.

DLD Asset Management first reported a position in OACCW in Q4 2025 and has held it in 2 quarters since. 27 funds tracked by Wall St. Rank hold OACCW as of Q2 2026.

  • DLD Asset Management held 44,519 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $41.9K as of Q2 2026.
  • Oaktree Acquisition Corp III Life Sciences Warrant was a new DLD Asset Management position in Q2 2026.
  • Oaktree Acquisition Corp III Life Sciences Warrant made up ﹤0.01% of DLD Asset Management's portfolio in Q2 2026, its #336 holding.
  • DLD Asset Management first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q4 2025 and has held it in 2 quarters since.
  • 27 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q2 2026.

Based on DLD Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.